The indigenous COVID-19 vaccine being developed by a partnership between the ICMR and Bharat Biotech generates immune response according to results released in a preprint paper titled ‘A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine- BBV152’.
from The Hindu - National https://ift.tt/3p0qK3c
0 comments:
Post a Comment